Relentless Positioning For The Downside
Like a terrier on a mailman’s leg, positioning short biotech via LABD, has been relentless (not advice, not a recommendation).
This update details the current positioning via 3X, Leveraged Inverse Fund, LABD.
This is not investment advice; this site has no obligation to provide the following information.
However, as stated in the About section, one of the purposes here, is to document trade actions and results.
With that in mind, the green arrows show the locations of LABD entries for the short-biotech (SBPBIO) trade identified as LABD-22-05.
Biotech SPBIO, 3X Leveraged Inverse Fund LABD, Daily
The magenta arrow at the far right of the chart, is the ‘break-even’ point. It’s about 1.75 – 2.0 points away from the current price.
Note: This is not ‘Dollar Cost Averaging’.
Few in the industry know that ‘dollar cost averaging’ is based on a scam conducted by the bucket shops in the early 1900s.
It’s comforting to know, that method (the scam), has made its way into at least one SEC certification requirement.
There, I feel much better 🙂
One of, if not the main reason for working this trade with the current method, is the real danger this market could ‘implode’ at any minute.
We’re just one (un)planned event away from being down 20% – 50% overnight.
Biotech SPBIO ($SPSIBI), Weekly Close
The weekly close shows SPBIO to be unique among all the major indices (miners excluded).
Not even the sister index IBB, has the weekly MA cross (black arrow) to the downside.
“You Are Here”
On the chart below, the complete positioning short SPBIO is shown as the magenta rectangle.
Also shown, are measured move targets.
Looking at the potential of this trade, the reason for the dogged persistence becomes clear.
As always, anything can happen … the trade could fall apart.
However, probabilities for continued market downside are increasing, not decreasing.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279